CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Crescendo Bioscience announced that the Wadsworth Center at the New York Department of Health, through its Clinical Laboratory Evaluation Program, issued a laboratory permit to Crescendo Bioscience to provide services to physicians in New York.
Crescendo offers Vectra DA, a multi-biomarker blood test that measures disease activity in rheumatoid arthritis by integrating 12 key proteins consistently associated with the biology of RA into one objective, quantitative score to help physicians make more informed patient management decisions. Vectra DA is now available in all 50 states.
Crescendo Bioscience, 650-351-1354